Marshall Wace, LLP Beyond Air, Inc. Transaction History

Marshall Wace, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$5.65 - $7.56 $111,220 - $148,818	19,685 Added 58.62%	53,265 $359,000
Q4 2022 Feb 14, 2023	BUY	$5.47 - $7.9 $183,682 - $265,282	33,580 New	33,580 $217,000
Q2 2022 Aug 15, 2022	BUY	$4.96 - $7.83 $124,679 - $196,822	25,137 Added 29.01%	111,779 $748,000
Q1 2022 May 16, 2022	BUY	$6.33 - $9.53 $548,443 - $825,698	86,642 New	86,642 $578,000
Q4 2021 Feb 14, 2022	SELL	$8.44 - $15.61 $814,485 - $1.51 Million	-96,503 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.9 - $12.54 $409,696 - $870,777	69,440 Added 256.59%	96,503 $1.07 Million
Q2 2021 Aug 13, 2021	BUY	$4.72 - $7.15 $127,737 - $193,500	27,063 New	27,063 $175,000

11.1M

54.4K

Ticker XAIR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,888,000
Market Cap $17M
Description
Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.